Jay Stout Insider Trades & Stock Holdings

Chief Technology Officer · Immunovant, Inc. · Latest filing Jun 26, 2026

Jay Stout, Chief Technology Officer at Immunovant, Inc. has 1 Form 4 trade on file since Jun 26, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($1.53M), net -$1.53M. Latest filing: disposed of 40K shares of $IMVT on Jun 26, 2026 at $38.31.

Trades on file

1

Open-market bought

$0

Open-market sold

$1.53M

Net open-market

-$1.53M

Latest filing

Jun 26, 2026

All insider trades by Jay Stout

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 26, 2026	$IMVT	Sell (Open-market sale)	40K	$38.31	$1.53M			-0.6%	+3.2%		Chief Technology Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Jay Stout traded

• $IMVT

Frequently asked questions

Has Jay Stout been buying or selling stock?

Jay Stout has 0 open-market purchases and 1 open-market sale on file, net -$1.53M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Jay Stout's latest insider trade?

disposed of 40K shares of $IMVT on Jun 26, 2026 at $38.31.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.